Erythrocyte sedimentation rate as an independent prognostic factor in mycosis fungoides

British Journal of Dermatology

Volumn 166, Issue 4, 2012, Pages 873-874

  Hallermann, C ^a   Niermann, C ^a   Fischer, R J ^b   Schulze, H J ^b  

^a Fachklinik Hornheide ^*  (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANEMIA; ARTICLE; BLOOD; CANCER STAGING; CLINICAL ARTICLE; DISEASE SPECIFIC SURVIVAL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LYMPH NODE; LYMPHOMA; MYCOSIS FUNGOIDES; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX; SURVIVAL; VISCERA;

BLOOD SEDIMENTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MYCOSIS FUNGOIDES; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84859127861     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10729.x     Document Type: Article

References (10)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.
2. Hallermann C, Niermann C, Fischer RJ, Schulze HJ,. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study. Acta Derm Venereol (Stockh) 2011; 91: 521-5.
3. Sox A, Liang MH,. The erythrocyte sedimentation rate. Guideline for rational use. Ann Intern Med 1986; 104: 515-23.
4. Spivak JL,. The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer 2005; 5: 543-53.
5. Zinzani PL, Tani M, Alinari L, et al. Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. Leuk Lymphoma 2005; 46: 1449-54.
6. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713-22.
7. Bunn PA Jr, Lamberg SI,. Report on the commitee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979; 63: 725-8.
8. Coiffier B,. Prognostic factors in Hodgkin's and non-Hodgkin's lymphomas. Curr Opin Oncol 1991; 3: 843-51.
9. Bremnes RM, Bremnes Y, Dønnem T,. High-grade non-Hodgkin's lymphoma treated in northern Norway-treatment, outcome, and prognostic factors. Acta Oncol 1999; 38: 117-24.
10. Alici S, Bavbek SE, Kaytan E, et al. Prognostic factors in localized aggressive non-Hodgkin's lymphoma. Am J Clin Oncol 2003; 26: 1-5.